Status:
TERMINATED
Af Ablation In Brady-Tachy Syndrome
Lead Sponsor:
Abbott Medical Devices
Conditions:
Brady-tachy Syndrome
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of the study is to evaluate the impact of atrial fibrillation ablation in patients presenting a brady-tachy syndrome on the AF burden. The hypothesis of the study is that AF ablation prevents...
Detailed Description
The study is a randomized study 1:1 AF ablation vs non AF ablation. Patients are followed for 1 year. 38 patients will be required to show a significant reduction in AF burden.
Eligibility Criteria
Inclusion
- paroxystic AF
- symptomatic pauses (\>5s at night or 3s during daytime)
Exclusion
- permanent AF
- age \> 80 y
- pregnant women
- minors
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00740272
Start Date
March 1 2008
End Date
December 1 2009
Last Update
February 4 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital St joseph
Marseille, France
2
CHU
Rouen, France
3
Clinique Pasteur
Toulouse, France